Latham & Watkins represented Parsons Corporation in the transaction. Parsons Corporation (NYSE:PSN) has announced that it entered into a definitive agreement to acquire Xator Corporation in...
Parsons’ Acquisition of Xator Corporation
HilleVax’s $200 Million Initial Public Offering
Latham & Watkins represented HilleVax, while Davis Polk advised the joint book-running managers in the IPO. HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and...
Avient Corporation’s EUR 1.44 Billion Acquisition of Royal DSM’s Protective Materials Business
Clifford Chance has advised Royal DSM on the deal while Jones Day represented Avient Corporation. Royal DSM, a global purpose-led science-based company, agreed to sell its...
Ligand’s Spin-off of OmniAb Business
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
Galderma’s Acquisition of Alastin Skincare
Ropes & Gray advised Galderma on the deal, while Latham & Watkins advised ALASTIN. Galderma, one of the world’s largest independent dermatology companies, executed its acquisition...
Cast & Crew’s Acquisition of The Team Companies
Latham & Watkins represented Cast & Crew in the transaction. Cast & Crew, a leading international provider of mission-critical software and technology-driven services to the entertainment industry, has...
GlobalFoundries’ Initial Public Offering
Cleary Gottlieb Steen & Hamilton represented GlobalFoundries in the offering, while Latham & Watkins represented the underwriters. GlobalFoundries® (GF®), a global leader in feature-rich semiconductor manufacturing, announced...
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Capital Dynamics’ Lift-Out Of US Clean Energy Infrastructure Funds By Investor Consortium
Clifford Chance advised Capital Dynamics on the matter. Capital Dynamics lifted-out certain US clean energy infrastructure (CEI) funds by APG, California State Teachers’ Retirement System, and...
Icosavax’s $209.3 Million IPO
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
Erasca’s $345 Million Initial Public Offering
Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...